董春红

董春红 discloses dealings in 拓新药业 to SSE / SZSE (CSRC). Between 28 November 2022 and 23 February 2023, the trades on record add up to 2 filings.

Sales make up the whole of the open-market record (2 sales, €1.9M). In 2023 alone, the filings show no purchases and 1 sale.

The latest filing, published on 23 February 2023, reports an open-market sale of €491k in 拓新药业. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.